coronavirus

GreenLight receives Rwanda FDA approval for Covid-19 mRNA vaccine trial

GreenLight Biosciences has received the Rwanda Food and Drugs Authority (Rwanda FDA) approval for a Phase I/II clinical trial of…

Dyadic initiates subject dosing in Phase I trial of Covid-19 booster

Dyadic International has initiated subject dosing in its Phase I clinical trial of the Covid-19 recombinant protein receptor binding domain…

Tevogen Bio reports positive data from Covid-19 T cell therapy trial

Tevogen Bio has reported positive topline data from a clinical trial of off-the-shelf, allogeneic cytotoxic CD8+ T cell therapy TVGN…

Ascletis doses subjects in first cohort of Covid-19 oral therapy trial

Ascletis Pharma has dosed the first cohort’s four healthy participants in a Phase I clinical trial of its oral therapy…

American CryoStem to proceed with Phase I Covid-19 cell therapy trial

American CryoStem is set to proceed with a Phase I clinical trial of its ATCELL therapy to treat Long Covid/PASC,…

Meiji Seika Pharma commences Phase III mRNA Covid-19 vaccine trial in Japan

Meijisubsidiary Meiji Seika Pharma has commenced a Phase III clinical trial of a messenger ribonucleic acid (mRNA) vaccine, ARCT-154, for…

Ascletis reports positive data from Phase I Covid-19 prodrug trial

Ascletis Pharma has reported positive topline data from the Phase I multiple ascending dose (MAD) clinical trial of its prodrug, ASC10, in…

China NMPA grants IND clearance for trial of Ascletis’ Covid-19 drug

The China National Medical Products Administration (NMPA) has granted approval for Ascletis Pharma’s Investigational New Drug (IND) application for the Phase I…

US FDA grants clearance to commence trials of Sorrento’s mRNA vaccine

The US Food and Drug Administration (FDA) has granted clearance to Sorrento Therapeutics to commence clinical trials of the messenger ribonucleic acid…

Anticoagulant unbeneficial for Covid-19 University of Cambridge trial finds

The University of Cambridge in the UK has reported results from the HEAL-COVID clinical trial, where the oral anticoagulant Apixaban…